Evidence map›Paper›PMID 15618210›Full record

ArticleInfection and immunity2005

Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell.

Cheryl-Ann Lobo

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Immunity beyond borders: non-lethalFrontiers in immunology · 2026
    Article
  5. Host-pathogen interactions involved in erythrocyte invasion byFrontiers in cellular and infection microbiology · 2025
    Article
  6. Identification ofInfection and immunity · 2024
    Article
  7. Article
  8. Establishment of ContinuousMicrobiology spectrum · 2023
    Article
  9. Review
  10. Article
  11. Establishment of a stable transfection and gene targeting system inFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
  13. Article
  14. Plasmepsin-like Aspartyl Proteases inPathogens (Basel, Switzerland) · 2021
    Article
  15. Review
  16. International journal of molecular sciences · 2021
    Article
  17. Lessons Learned for Pathogenesis, Immunology, and Disease of Erythrocytic Parasites:Frontiers in cellular and infection microbiology · 2021
    Review
  18. Review
  19. An Overview of Current Knowledge onFrontiers in veterinary science · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Cheryl-Ann LoboMailing address: Molecular Parasitology, Lindsley Kimball Research Institute, New York Blood Center, 310 E. 67th St., New York, NY 10021, USA. clobo@nybloodcenter.org
New York Blood Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Babesiosis has long been recognized as an economically important disease of cattle, but only in the last 30 years has Babesia been recognized as an important pathogen in humans. Invasion of erythrocytes is an integral part of the Babesia life cycle. However, very little information is available on the molecules involved in this process, in contrast to another hemoparasite, Plasmodium falciparum. Using invasion assays into normal red blood cells (RBCs), enzyme-treated cells, and clinically mutant cells, we showed that Babesia divergens uses neuraminidase- and trypsin-sensitive receptors to enter the RBCs, of which glycophorins A and B are the prominent ones. These results could have broad implications relating to evolutionarily conserved mechanisms of host cell entry in these related Apicomplexan parasites and pave the way toward a detailed molecular analysis of erythrocyte invasion in B. divergens.

Indexed as

AnimalsBabesiaErythrocytesGlycophorinsHumansPlasmodium falciparumGlycophorins

Identifiers

PMID15618210
PMCPMC538995
OpenAlexW2165594194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.